Literature DB >> 26744058

Blood-brain barrier crossing and breakthroughs in glioblastoma therapy.

P Sminia1, B A Westerman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26744058      PMCID： PMC4876176          DOI： 10.1111/bcp.12881

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Blood-brain barrier crossing and breakthroughs in glioblastoma therapy.

Authors:  P Sminia; B A Westerman
Journal:  Br J Clin Pharmacol       Date:  2016-02-08       Impact factor: 4.335

Review 2.  The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology.

Authors:  J S Good; K J Harrington
Journal:  Clin Oncol (R Coll Radiol)       Date:  2013-07-10       Impact factor: 4.126

Review 3.  Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?

Authors:  Michael Fay; Richard Head; Jennifer Martin
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

Review 4.  Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.

Authors:  Jayson I L Bastien; Katharine A McNeill; Howard A Fine
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

Review 5.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 6.  Interaction of radiation therapy with molecular targeted agents.

Authors:  Zachary S Morris; Paul M Harari
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

7.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

Review 8.  Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

Authors:  Dayle Rundle-Thiele; Richard Head; Leah Cosgrove; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

Review 9.  Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

Authors:  O van Tellingen; B Yetkin-Arik; M C de Gooijer; P Wesseling; T Wurdinger; H E de Vries
Journal:  Drug Resist Updat       Date:  2015-03-06       Impact factor: 18.500

10.  Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101).

Authors:  Pieter J Gaillard; Chantal C M Appeldoorn; Rick Dorland; Joan van Kregten; Francesca Manca; Danielle J Vugts; Bert Windhorst; Guus A M S van Dongen; Helga E de Vries; David Maussang; Olaf van Tellingen
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240
View more
  4 in total

1.  Blood-brain barrier crossing and breakthroughs in glioblastoma therapy.

Authors:  P Sminia; B A Westerman
Journal:  Br J Clin Pharmacol       Date:  2016-02-08       Impact factor: 4.335

Review 2.  A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.

Authors:  Da Wang; Chao Wang; Liang Wang; Yue Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

3.  Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.

Authors:  Fatima Bikhezar; Robin M de Kruijff; Astrid J G M van der Meer; Guzman Torrelo Villa; Susanne M A van der Pol; Gabriel Becerril Aragon; Ana Gasol Garcia; Ravi S Narayan; Helga E de Vries; Ben J Slotman; Antonia G Denkova; Peter Sminia
Journal:  J Neurooncol       Date:  2019-12-24       Impact factor: 4.130

Review 4.  Oncolytic Viruses for Malignant Glioma: On the Verge of Success?

Authors:  Yogesh R Suryawanshi; Autumn J Schulze
Journal:  Viruses       Date:  2021-07-02       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.